Effects of chronotherapy on neutrophils in breast cancer patients
10.3760/cma.j.issn.1672-7088.2015.23.002
- VernacularTitle:乳腺癌时辰治疗对患者中性粒细胞的影响
- Author:
Jian ZHOU
;
Xiaohong LYU
;
Xiumei KUANG
;
Jie HAN
;
Yingyan BI
;
Yanjun LIU
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Chronotherapy;
Drug therapy;
Neutropenia;
Critical pathways
- From:
Chinese Journal of Practical Nursing
2015;31(23):1720-1723
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of chronotherapy (chemotherapy plus timely medication) on neutrophils in breast cancer patients with neoadjuvant chemotherapy.Methods Fifty breast cancer patients with neoadjuvant chemotherapy were selected from 2011 to 2014 and divided into chronotherapy group and conventional treatment group (conventional group) by random number table method with 25 cases each.Conventional group received conventional neoadjuvant chemotherapy and conventional drug treatment.Chronotherapy group received neoadjuvant chemotherapy combined with chronochemotherapy and timely medication treatment,and applied clinical nursing care pathway.Both groups were conducted three cycles of chemotherapy,three weeks after the first and the second chemotherapy,the results of routine blood and liver function were compared in patients between two groups.The number of readmission and fever because of agranulocytosis were calculated.Results The two groups of patients were successfully completed three cycles of chemotherapy,after the first cycle of chemotherapy,the neutrophil was (4.40 ± 2.20)x109/L in chronotherapy group,and (3.18 ± 1.35) × 109/L in conventional group;after the second cycle of chemotherapy,the neutrophil was (3.95 ± 1.58) × 109/L,and (2.83 ± 1.49) x 109/L in conventional group,the two groups were statistically significant,t=2.375,2.563,P ＜0.05.Two cases needed readmission in chronotherapy group during chemotherapy,accounting for 8％(2/25),much lower than conventional group of 8 cases accounting for 32％(8/25).Conclusions The use of chronotherapy in breast cancer chemotherapy has less neutropenia,mild side effects of bone marrow suppression.It is an effective and safe viable option.
